| |
| |
|
| Insider
Information: |
Patel Kinnari |
| Relationship: |
|
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
271,634 |
|
|
Indirect Shares
|
107,269 |
|
|
| Direct
Value |
$6,345,370 |
|
|
|
Indirect Value
|
$2,505,804 |
|
|
| Total
Shares |
378,903 |
|
|
| Total
Value |
$8,851,174 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
3
|
|
Stock
price went up :
|
1
|
2
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
2.0
|
| Percentage
Gain/Loss : |
 229.9%
|
57.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Rocket Pharmaceuticals |
RCKT |
|
2024-02-16 |
271,634 |
2024-02-16 |
107,269 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
15 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RCKT |
Rocket Pharmaceuticals |
See Remarks |
• • – |
2024-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
33,288 |
271,634 |
0 |
- |
|
| RCKT |
Rocket Pharmaceuticals |
See Remarks |
• • – |
2024-02-16 |
4 |
S |
$29.84 |
$212,805 |
D/D |
(7,132) |
238,346 |
0 |
% |
|
| RCKT |
Rocket Pharmaceuticals |
See Remarks |
• • – |
2024-02-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
26,189 |
245,478 |
0 |
- |
|
| RCKT |
Rocket Pharmaceuticals |
See Remarks |
• • – |
2023-11-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,989 |
220,437 |
0 |
- |
|
| RCKT |
Rocket Pharmaceuticals |
See Remarks |
• • – |
2023-10-05 |
4 |
OE |
$0.00 |
$0 |
I/I |
3,333 |
101,594 |
0 |
- |
|
| RCKT |
Rocket Pharmaceuticals |
See Remarks |
• • – |
2023-08-17 |
4 |
S |
$15.47 |
$23,733 |
D/D |
(1,534) |
216,448 |
0 |
% |
|
| RCKT |
Rocket Pharmaceuticals |
See Remarks |
• • – |
2023-08-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,989 |
217,982 |
0 |
- |
|
| RCKT |
Rocket Pharmaceuticals |
See Remarks |
• • – |
2023-05-17 |
4 |
S |
$21.38 |
$28,429 |
D/D |
(1,330) |
213,993 |
0 |
% |
|
| RCKT |
Rocket Pharmaceuticals |
See Remarks |
• • – |
2023-05-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,989 |
215,323 |
0 |
- |
|
| RCKT |
Rocket Pharmaceuticals |
See Remarks |
• • – |
2023-02-14 |
4/A |
OE |
$0.00 |
$0 |
D/D |
15,720 |
166,566 |
0 |
- |
|
| RCKT |
Rocket Pharmaceuticals |
Chief Operating Officer |
• • – |
2021-03-24 |
4 |
OE |
$1.21 |
$131,979 |
D/D |
93,962 |
188,939 |
0 |
- |
|
| RCKT |
Rocket Pharmaceuticals |
Chief Operating Officer |
• • – |
2020-12-28 |
4 |
AS |
$56.51 |
$950,745 |
D/D |
(16,761) |
94,977 |
0 |
% |
|
| RCKT |
Rocket Pharmaceuticals |
Chief Operating Officer |
• • – |
2020-03-18 |
4 |
B |
$9.50 |
$9,500 |
I/I |
1,000 |
6,675 |
0.01 |
% |
|
| RCKT |
Rocket Pharmaceuticals |
Chief Operating Officer |
• • – |
2018-12-20 |
4 |
OE |
$1.21 |
$67,601 |
D/D |
55,869 |
55,869 |
0 |
- |
|
| RCKT |
Rocket Pharmaceuticals |
Chief Operating Officer |
• • – |
2018-12-06 |
4 |
B |
$14.98 |
$85,012 |
I/I |
5,675 |
5,675 |
0.01 |
- |
|
15 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
